Abstract
AMPK (AMP-activated protein kinase) is a serine/threonine kinase that functions as a metabolic master switch by regulating ATP consuming anabolic pathways and ATP generating catabolic pathways in response to cellular energy status. It is activated in response to stresses such as: diabetes, hypoxia, toxins, nutrient deprivation, hormones and drugs. Although most of the known functions of AMPK are due to regulation of metabolic enzyme activity in cytoplasm, a growing body of evidence suggests that AMPK also functions as major regulator of metabolic gene expression. Here I review our current understanding of how AMPK regulates gene expression at the transcriptional, mRNA stability, and protein synthesis levels.
Keywords: ampk, aicar, fkhr, hnf-a, chrebp, ppar, hur, importin a/b
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Title: AMP-Activated Protein Kinase (AMPK): Regulation of Metabolic Gene Expression
Volume: 5 Issue: 5
Author(s): U. S. Varanasi
Affiliation:
Keywords: ampk, aicar, fkhr, hnf-a, chrebp, ppar, hur, importin a/b
Abstract: AMPK (AMP-activated protein kinase) is a serine/threonine kinase that functions as a metabolic master switch by regulating ATP consuming anabolic pathways and ATP generating catabolic pathways in response to cellular energy status. It is activated in response to stresses such as: diabetes, hypoxia, toxins, nutrient deprivation, hormones and drugs. Although most of the known functions of AMPK are due to regulation of metabolic enzyme activity in cytoplasm, a growing body of evidence suggests that AMPK also functions as major regulator of metabolic gene expression. Here I review our current understanding of how AMPK regulates gene expression at the transcriptional, mRNA stability, and protein synthesis levels.
Export Options
About this article
Cite this article as:
Varanasi S. U., AMP-Activated Protein Kinase (AMPK): Regulation of Metabolic Gene Expression, Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents 2005; 5 (5) . https://dx.doi.org/10.2174/156801305774322457
DOI https://dx.doi.org/10.2174/156801305774322457 |
Print ISSN 1568-0134 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0134 |
Related Articles
-
Immunoglobulin Therapy, Myocardial Diseases and Atherosclerosis:Recent Experimental and Clinical Studies
Current Cardiology Reviews Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Traditional and Alternative Therapies for Refractory Angina
Current Pharmaceutical Design Topoisomerase Enzymes as Therapeutic Targets for Cancer Chemotherapy
Medicinal Chemistry Mitochondrial Uncoupler Proteins
Current Enzyme Inhibition Cardio-Protective Effects of Sodium-Glucose Co-Transporter 2 Inhibitors: Focus on Heart Failure
Current Pharmaceutical Design Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Current Medicinal Chemistry Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Characterizing the Bi-Subunit Type IB DNA Topoisomerase of Leishmania Parasites; a Novel Scenario for Drug Intervention in Trypanosomatids
Current Drug Targets Technological Innovations in Magnetic Resonance for Early Detection of Cardiovascular Diseases
Current Pharmaceutical Design New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives
Current Pharmaceutical Design Amniotic Fluid Embolism: Moving Diagnosis Through the Time. From the Mechanical Pulmonary Vascular Occlusion Until An Immuno - Inflammatory Pathogenesis?
Current Pharmaceutical Biotechnology Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Tissue Doppler Imaging: Beautiful Noise
Current Cardiology Reviews Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Current Topics in Medicinal Chemistry The Evolving Therapy of Rheumatic Diseases, The Future is Now
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeted Nucleic Acid Delivery to Mitochondria
Current Gene Therapy Investigating Mitochondrial Dysfunction to Increase Drug Safety in the Pharmaceutical Industry
Current Drug Targets Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications
Current Reviews in Clinical and Experimental Pharmacology Truncated Human Cathepsin L, Encoded by a Novel Splice Variant, Exhibits Altered Subcellular Localization and Cytotoxicity
Protein & Peptide Letters